GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …
Kidney cancer patients in Wales are to gain access to the four new drugs that are still denied on the …
UK watchdog's guidance knocks kidney cancer drugsThe UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted …
Avastin has been launched in the UK as a first-line treatment for renal cell carcinoma (RCC) to be used in …

